BioNTech SE (NASDAQ: BNTX) reported Q2 EPS of (EUR2.22), EUR0.18 worse than the analyst estimate of (EUR2.04). Revenue for the quarter came in at EUR105.6 million versus the consensus estimate of EUR162.59 million.

For earnings history and earnings-related data on BioNTech SE (BNTX) click here.